Company profile LYRA

Lyra Therapeutics Inc
lyra therapeutics, inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. the company's xtreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single a...dministration. its product candidates include lyr-210 and lyr-220, which are bioresorbable polymeric matrices for the treatment of chronic rhinosinusitis. the company was formerly known as 480 biomedical, inc. and changed its name to lyra therapeutics, inc. in july 2018. lyra therapeutics, inc. was founded in 2005 and is headquartered in watertown, massachusetts. Show More
Quarter analysis & expected interestLast update: February 07 2024 22:53:16.

After 38 days of this quarter the interest is at 37.0. Based on that we can calculate that during remaining 53 days it will total up to 89.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
20199
76
744.4% QoQ
134
76.3% QoQ
65
-51.5% QoQ
2020 108
1100.0% YoY 66.2% QoQ
223
193.4% YoY 106.5% QoQ
138
3.0% YoY -38.1% QoQ
63
-3.1% YoY -54.3% QoQ
2021 32
-70.4% YoY -49.2% QoQ
49
-78.0% YoY 53.1% QoQ
76
-44.9% YoY 55.1% QoQ
99
57.1% YoY 30.3% QoQ
2022 71
121.9% YoY -28.3% QoQ
85
73.5% YoY 19.7% QoQ
35
-53.9% YoY -58.8% QoQ
77
-22.2% YoY 120.0% QoQ
2023 96
35.2% YoY 24.7% QoQ
81
-4.7% YoY -15.6% QoQ
156
345.7% YoY 92.6% QoQ
104
35.1% YoY -33.3% QoQ
2024 37
-61.5% YoY -64.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Lyra Therapeutics search interestLast update: February 07 2024 22:53:16.
Correlation coefficient between keyword and revenue is 0.03
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 22:53:17.

The average 5 years interest of Lyra Therapeutics was 6.98 per week.
The last year interest of Lyra Therapeutics compared to the last 5 years has changed by 26.5%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 56.28%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 07 2024 22:53:22.

After 38 days of this quarter the interest is at 41.0. Based on that we can calculate that during remaining 53 days it will total up to 98.0.
Lyra Therapeutics stock expected interest is significantly higher compared to same quarter last year (+226.7%) but similar to previous quarter.

YearQ1Q2Q3Q4
201970
20
-71.4% QoQ
232
1060.0% QoQ
36
-84.5% QoQ
2020 81
15.7% YoY 125.0% QoQ
98
390.0% YoY 21.0% QoQ
47
-79.7% YoY -52.0% QoQ
91
152.8% YoY 93.6% QoQ
2021 48
-40.7% YoY -47.3% QoQ
127
29.6% YoY 164.6% QoQ
79
68.1% YoY -37.8% QoQ
37
-59.3% YoY -53.2% QoQ
2022 0
-100.0% YoY -100.0% QoQ
45
-64.6% YoY inf% QoQ
140
77.2% YoY 211.1% QoQ
11
-70.3% YoY -92.1% QoQ
2023 30
inf% YoY 172.7% QoQ
166
268.9% YoY 453.3% QoQ
126
-10.0% YoY -24.1% QoQ
81
636.4% YoY -35.7% QoQ
2024 41
36.7% YoY -49.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Lyra Therapeutics stock search interestLast update: February 07 2024 22:53:21.
Correlation coefficient between keyword and revenue is 0.66
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 22:53:24.

The average 5 years interest of Lyra Therapeutics stock was 6.18 per week.
The last year interest of Lyra Therapeutics stock compared to the last 5 years has changed by 38.19%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 7.56%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Lyra Therapeutics news to provide analysis

Correlation between past revenue and Lyra Therapeutics news search interest

There is not enough data for Lyra Therapeutics news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Lyra Therapeutics news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Lyra Therapeutics clinical trials to provide analysis

Correlation between past revenue and Lyra Therapeutics clinical trials search interest

There is not enough data for Lyra Therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Lyra Therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Lyra Therapeutics products to provide analysis

Correlation between past revenue and Lyra Therapeutics products search interest

There is not enough data for Lyra Therapeutics products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Lyra Therapeutics products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Lyra Therapeutics contact to provide analysis

Correlation between past revenue and Lyra Therapeutics contact search interest

There is not enough data for Lyra Therapeutics contact to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Lyra Therapeutics contact to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Lyra Therapeutics headquarters to provide analysis

Correlation between past revenue and Lyra Therapeutics headquarters search interest

There is not enough data for Lyra Therapeutics headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Lyra Therapeutics headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Lyra Therapeutics biotechnology to provide analysis

Correlation between past revenue and Lyra Therapeutics biotechnology search interest

There is not enough data for Lyra Therapeutics biotechnology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Lyra Therapeutics biotechnology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Lyra Therapeutics healthcare to provide analysis

Correlation between past revenue and Lyra Therapeutics healthcare search interest

There is not enough data for Lyra Therapeutics healthcare to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Lyra Therapeutics healthcare to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for LYRA
Earnings date: 2024-03-06 After close
Company name: Lyra Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-04-17T12:00:00Z

GlobeNewswire
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC

2026-01-12T12:00:00Z

GlobeNewswire
Lyra Therapeutics Provides Corporate Update

2025-11-12T21:01:00Z

GlobeNewswire
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

2025-10-14T15:09:11-04:00

SEC
144 Form - Report of proposed sale of securities - Lyra Therapeutics, Inc. (0001327273) (Subject)

2025-10-08T16:30:03-04:00

SEC
4/A Form - [Amend] Statement of changes in beneficial ownership of securities - Lyra Therapeutics, Inc. (0001327273) (Issuer)

2025-10-06T11:00:00Z

GlobeNewswire
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study

2025-10-03T16:15:09-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Lyra Therapeutics, Inc. (0001327273) (Issuer)

2025-09-04T08:01:28-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - Lyra Therapeutics, Inc. (0001327273) (Filer)

2025-08-22T16:15:15-04:00

SEC
8-K Form - Current report, item 3.01 - Lyra Therapeutics, Inc. (0001327273) (Filer)

2025-08-14T11:12:51Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Neutral on Lyra Therapeutics, Maintains $16 Price Target

2025-08-12T20:01:00Z

GlobeNewswire
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

2025-08-01T16:02:49-04:00

SEC
8-K Form - Current report, item 5.02 - Lyra Therapeutics, Inc. (0001327273) (Filer)

2025-07-31T00:15:28-04:00

SEC
EFFECT Form - Notice of Effectiveness - Lyra Therapeutics, Inc. (0001327273) (Filer)

2025-07-22T17:15:05-04:00

SEC
S-1 Form - General form for registration of securities under the Securities Act of 1933 - Lyra Therapeutics, Inc. (0001327273) (Filer)

2025-06-27T12:00:00Z

GlobeNewswire
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules